Geriatric nutritional risk index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis

Y Mochizuka, Y Suzuki, M Kono, H Hasegawa… - …, 2023 - Wiley Online Library
Abstract Background and Objective Idiopathic pulmonary fibrosis (IPF) is characterized by
progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested …

Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients

S Jouneau, C Rousseau, M Lederlin, A Lescoat… - Clinical Nutrition, 2022 - Elsevier
Introduction and aims Malnutrition is frequent in patients with idiopathic pulmonary fibrosis
(IPF). We examined the relationship between malnutrition at diagnosis and all-cause …

The clinical significance of body weight loss in idiopathic pulmonary fibrosis patients

Y Nakatsuka, T Handa, M Kokosi, K Tanizawa… - Respiration, 2018 - karger.com
Background: The significance of the nutritional status in idiopathic pulmonary fibrosis (IPF) is
largely unknown. Temporal body weight (BW) change, a dynamic index of nutrition status …

Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis

A Perelas, J Glennie, K van Kerkhove, M Li… - Pulmonary …, 2019 - Elsevier
Purpose Although safety and tolerability of approved antifibrotics has been reported
extensively, little is known about their effects on weight. We analyzed predictors of weight …

What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center

S Jouneau, M Kerjouan, C Rousseau, M Lederlin… - Nutrition, 2019 - Elsevier
Objectives Little is known about the indicators to assess malnutrition in patients with
idiopathic pulmonary fibrosis (IPF). This study aimed to determine the following: 1) the …

Association between weight loss and mortality in idiopathic pulmonary fibrosis

A Kalininskiy, AR Rackow, D Nagel, D Croft… - Respiratory …, 2022 - Springer
Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung
disease that has no cure. Many current research efforts center on diagnostic and therapeutic …

Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone

TH Kim, YY Shin, HJ Kim, MJ Song, YW Kim, SY Lim… - Scientific Reports, 2022 - nature.com
There have been limited studies on the association between prognosis and body weight
change in patients with idiopathic pulmonary fibrosis (IPF). This single-center retrospective …

Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study

P Faverio, A Fumagalli, S Conti, F Madotto… - ERJ Open …, 2022 - Eur Respiratory Soc
Background Nutritional status impacts quality of life and prognosis of patients with
respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack …

Clinical impact of weight loss on mortality in patients with idiopathic pulmonary fibrosis: a retrospective cohort study

JK Lee, C Chung, J Kim, HS Cho, HC Kim - Scientific Reports, 2023 - nature.com
Patients with idiopathic pulmonary fibrosis (IPF) often experience weight loss during the
follow-up period. However, the prevalence and clinical impact of weight loss in these …

Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy

Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …